Private Placement

AvenCell has dosed the first patient with AVC-203, a novel allogeneic CAR-T therapy, aiming to make advanced cancer treatment more accessible and effective.

Geely-backed CaoCao Inc. is the first to get approval for unmanned Robotaxi testing in Hangzhou, accelerating the race against rivals like Baidu and WeRide.

Wheaton Precious Metals enters Australia with a landmark streaming deal, funding KGL's Jervois copper mine and tapping into critical metals for the green economy.

Riding the wave of an Oprah endorsement, D2C powerhouse GOAT Foods lands a strategic credit facility to refinance debt and accelerate its rapid growth.

Texan by Nature names its 2026 Conservation Wranglers, backing innovative projects from desert creeks to urban cemeteries to secure the state's future.

With a new technical report filed, Aventis Energy outlines its exploration strategy for the promising Sting Copper Project in a resource-rich region.

In a tough biotech market, NewcelX's $1.35M financing at a 30% premium signals strong confidence in its pioneering stem cell therapy for Type 1 Diabetes.

Wellness brand RäFoods launches a new fund linking product sales to childhood literacy and nutrition, a bold move in corporate social responsibility.

A 30-second 'Healthy Selfie' now detects metabolic risk. Backed by a $200K guarantee, this AI platform is set to redefine corporate wellness.

Biotech veteran Dr. Vince O'Neill joins Mosaic Therapeutics to spearhead its synergistic precision oncology pipeline, aiming to transform cancer treatment.

BDx Data Centers secures massive financing to build advanced, liquid-cooled AI facilities in Indonesia, escalating the region's high-stakes tech infrastructure race.

The carbon-tech firm slashes losses and touts a key SAF partnership, but dwindling cash reserves raise questions about its path to sustainable growth.

OBIO awards $100K to a cancer therapy startup and launches a new training program, directly addressing the systemic funding barriers for women in life sciences.

Serenity Medical's River stent is a landmark approval for severe IIH, a condition causing chronic pain and vision loss, primarily in young women.

Extell Development appoints Innovo founder Andrew Chung as Co-CEO, a move poised to reshape its capital strategy and diversify beyond luxury condos.

A new report reveals a huge gap between patient desires for holistic, less invasive fertility options and a system that defaults to costly IVF treatments.

Thaler Defense Systems appoints a new CEO and expands its leadership team to scale production for critical missile defense and space programs.

A novel drug aims to break down resistance in hard-to-treat lung and bile duct cancers, with key data set for a major oncology conference.

With a half-billion-dollar treasury of Canton Coin, this public firm is betting its future on becoming a key player in digitizing global finance.

Bolstered by a major investment and a key nuclear fusion deal, Next Hydrogen's new strategy and leadership signal a shift from R&D to commercial reality.